OraSure Technologies | OSUR - 销售收入



金融业
股票价格
USD
资产
USD 403.17M
现金及等价物
USD 199.28M
销售成本
USD 15.43M
流动资产
USD 261.91M
流动负债
USD 39.8M
债务
USD 782K
股息收益率
0
EBIT
USD -13.59M
EBITDA
USD -17.7M
员工
638
EPS每股收益
USD -0.18
股本和储备
USD 340.83M
销售毛利
USD 11.34M
债务利息支出
1.67M
贷款资金
USD 100K
市值
USD 225.8M
净收入
USD -19.29M
营业费用
USD 40.35M
营业利润
USD -13.59M
普通股股本
USD 70.39M
PE价格收益
24.42
税前利润
USD -18.43M
销售收入
USD 26.76M
销售和管理费用
USD 13.21M
股票
USD 31.06M
贸易债权人
USD 6.52M
应收帐款人
USD 22.2M


销售 更改 日
Agilent USD 1.8B 63M 2025-12
AngioDynamics USD 79.43M 3.72M 2025-09
Becton, Dickinson and Co. USD 5.3B 600M 2025-12
Bio Techne USD 295.9M 9.34M 2025-12
Bio-Rad Laboratories USD 693.2M 40.2M 2025-12
Bruker USD 977.2M 116.7M 2025-12
Cerus USD 50.81M 4.79M 2024-12
Charles River Laboratories USD 994.2M 5.8M 2025-12
Danaher USD 6.84B 790M 2025-12
Dentsply International USD 961M 57M 2025-12
Dexcom USD 1.26B 50M 2025-12
Hologic USD 1.05B 0 2025-12
Illumina USD 1.16B 80M 2025-12
Integra LifeSciences USD 434.9M 32.84M 2025-12
Intuitive Surgical USD 2.87B 360M 2025-12
IQVIA Holdings USD 4.36B 260M 2025-12
Mesa Laboratories USD 62.84M 5.01M 2024-12
Mettler Toledo International USD 1.13B 100M 2025-12
Myriad Genetics USD 209.8M 4.1M 2025-12
OraSure Technologies USD 26.76M 322K 2025-12
Quidel USD 724M 24M 2025-12
Repligen USD 197.91M 8.91M 2025-12
Revvity USD 772.06M 73.06M 2025-12
STAAR Surgical USD 239.4M 144.7M 2025-12
Thermo Fisher Scientific USD 12.21B 1.09B 2025-12
Trinity Biotech USD 14.31M 1.55M 2025-09
Waters USD 932M 132M 2025-12